Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

P Paolo Strati L Lei Feng J Jason R. Westin R Ranjit Nair L Luis E. Fayad M Maria A. Rodriguez D Dai Chihara L Luis Malpica J Jared Henderson M Mariana Gallardo M Marissa Rivera I Iris Wang A Anastasiia Bolshakova A Anastasia Radko D David Kurtz S Stefan K. Alig C Christopher R. Flowers (Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine) A Ash A. Alizadeh S Sattva S. Neelapu

Article Details

Volume / Issue Vol. 16, Issue 1
Published August 07, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (19)

P

Paolo Strati

L

Lei Feng

J

Jason R. Westin

R

Ranjit Nair

L

Luis E. Fayad

M

Maria A. Rodriguez

D

Dai Chihara

L

Luis Malpica

J

Jared Henderson

M

Mariana Gallardo

M

Marissa Rivera

I

Iris Wang

A

Anastasiia Bolshakova

A

Anastasia Radko

D

David Kurtz

S

Stefan K. Alig

C

Christopher R. Flowers

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

A

Ash A. Alizadeh

S

Sattva S. Neelapu